Reported Feb 24, 2021 · Terminated
Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufactured for and distributed by: KERYX…
Akebia Therapeutics dba Keryx Biopharmaceutials, Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Akebia Therapeutics dba Keryx Biopharmaceutials, Inc · 245 1st St · Cambridge, MA · 02142-1200
Is this the product you have?
- Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY
- Manufactured for and distributed byKERYX BIOPHARMACEUTICALS, INC., 245 First Street, Suite 1400, Cambridge, MA 02142, USA, NDC 59922-0631-01
- Lot codes and dates
- Lots #: CDKSN, CDPPH, Exp January 2022; Lot #: CDPPK, Exp February 2022.
- Amount recalled
- 17,664 bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Dissolution Specifications
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Akebia Therapeutics dba Keryx… recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.